Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Scientific monographs

Endocrinopathies and their connection with the gut microbiota: textbook

DOI
https://doi.org/10.36074/ecgm.textbook-2025
Published
2025-10-28

Abstract

The textbook «Endocrinopathies and their connection with the gut microbiota» was considered and approved at the meeting of the Department of Endocrinology (protocol No. 3 of 23.10.2025) and the specialized methodological commission on therapeutic disciplines of State non-profit enterprise «Danylo Halytsky National Medical University in Lviv» (protocol No. 6 of 04.11.2025).

⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

REVIEWERS:

URBANOVYCH Alina - Doctor of Medical Sciences, Professor, Head of the Department of Endocrinology, State non-profit enterprise «Danylo Halytsky National Medical University in Lviv»; Ukraine

LAPOVETS Lyubov - Doctor of Medical Sciences, Professor, Head of the Department of Clinical Laboratory Diagnostics, State non-profit enterprise «Danylo Halytsky National Medical University in Lviv»; Ukraine

⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

CONTENT:

ENTRY

1. FOUNDATION A TENDENCY TO METABOLIC DISORDERS, STARTING FROM THE INTRAUTERINE PERIOD OF THE FORMATION OF THE INTESTINAL MICROBIOTA AND AT THE STAGES OF THE LIFE OF A HUMAN HOST
1.1. The condition of the mother and the intrauterine period of the child's development
1.2. The factor of childbirth
1.3. Breastfeeding
1.4. Further stages from childhood to senile age

2. DETERMINING AXES OF INFLUENCE OF THE GUT MICROBIOTA
2.1. Intestines - brain
2.2. Intestines - skin
2.3. Intestines - heart
2.4. Intestines - lungs
2.5. Intestine - metabolism
2.6. Intestine - thyroid gland
2.7. Intestine - immune system

3. GUT MICROBIOTA IN DIABETES MELLITUS AND CONCOMITANT CONDITIONS, TAKING INTO ACCOUNT THE IODINE DEFICIENCY REGION
3.1. Fundamental discoveries as a basis and a guide for further scientific research
3.2. General view of the gut microbiota
3.3. The relationship of the intestinal microbiota with the appearance of pathological conditions related to endocrinopathies
3.4. The role of meta-inflammation and immune abnormalities in the development of endocrinopathies and comorbid conditions
3.5. Embryos of metabolic disorders in the pathogenesis of diabetes mellitus through the prism of changes in the gut and its microbiota

4. OWN RESEARCH AND ANALYSIS OF THE KEY COMPONENTS OF THE PATHOGENETIC PICTURE OF THE DEVELOPMENT OF THE STUDIED ENDOCRINOLOGICAL PATHOLOGIES

5. NATURAL AND MOTIVATING FACTORS CAN INFLUENCE THE GUT MICROBIOTA
5.1. Geographical location, ethnicity, diet and physical activity
5.2. Prebiotics, probiotics and intestinal microbiota transplantation

TEST QUESTIONS TO STUDY
LIST OF QUESTIONS FOR SELF-CONTROL OF KNOWLEDGE
REFERENCES
LIST OF SYMBOLS

⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯

Year of publication: 2025
Language: English
Authors: Moskva K.
Translation: No
Translator: -

Type: Paperbook
Number of pages: 118
Format: 148x210x16mm
ISBN: 979-8-89898-333-8
UDC: 616.441-008.63-06:616.34-008.87

References

  1. Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JY. Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism. Hepatology [online]. May 21. 2018 [cited 7 Feb 2023]; 68(4):1574-88. Available at: https://doi.org/10.1002/hep.29857
  2. Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI. Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome. Nature [online]. Jun. 2016 [cited 7 Feb. 2023]; 534(7606):213-7. Available on: https://doi.org/10.1038/nature18309
  3. Petersen C, Bell R, Klag KA, Lee SH, Soto R, Ghazaryan A, Buhrke K, Ekiz HA, Ost KS, Boudina S, O’Connell RM, Cox JE, Villanueva CJ, Stephens WZ, Round JL. T cell–mediated regulation of the microbiota protects against obesity. Science [online]. 25 Jul 2019 [cited 31 Jan. 2023]; 365(6451):eaat9351. Available on: https://doi.org/10.1126/science.aat9351
  4. Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, Rousseaux C, Dubuquoy C, Decourcelle C, Saudemont A, Tachon M, Béclin E, Odou MF, Neut C, Colombel JF, Desreumaux P. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut [Internet]. September 21. 2011 [cited 15 Jan. 2023]; 61(1):78-85. Available on: https://doi.org/10.1136/gutjnl-2011-300370
  5. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia [online]. 10 Oct. 2007 [cited December 28, 2022]; 50(12):2562-71. Available on: https://doi.org/10.1007/s00125-007-0834-6
  6. Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine [online]. 28 Nov. 2016 [cited 8 Feb. 2023]; 23(1):107-13. Available on: https://doi.org/10.1038/nm.4236
  7. Pop M. We are what we eat: how the diet of infants affects their gut microbiome. Genome Biol [online]. 2012 [cited 28 Apr 2023]; 13(4):152. Available on: https://doi.org/10.1186/gb-2012-13-4-152
  8. Prawitt J, Abdelkarim M, Stroeve JH, Popescu I, Duez H, Velagapudi VR, Dumont J, Bouchaert E, van Dijk TH, Lucas A, Dorchies E, Daoudi M, Lestavel S, Gonzalez FJ, Oresic M, Cariou B, Kuipers F, Caron S, Staels B. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes [Internet]. May 18. 2011 [cited 7 Feb. 2023]; 60(7):1861-71. Available on: https://doi.org/10.2337/db11-0030
  9. Prideaux L, Kang S, Wagner J, Buckley M, Mahar JE, De Cruz P, Wen Z, Chen L, Xia B, van Langenberg DR, Lockett T, Ng SC, Sung JJ, Desmond P, McSweeney C, Morrison M, Kirkwood CD, Kamm MA. Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease. Inflamm Bowel Dis [Internet]. Dec. 2013 [cited 30 Apr 2023]; 19(13):2906-18. Available on: https://doi.org/10.1097/01.mib.0000435759.05577.12
  10. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, etc. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature [online]. September 26. 2012 [cited December 26, 2022]; 490(7418):55-60. Available on: https://doi.org/10.1038/nature11450
  11. Ramezani A, Nolin TD, Barrows IR, Serrano MG, Buck GA, Regunathan-Shenk R, West RE, Latham PS, Amdur R, Raj DS. Gut colonization with methanogenic archaea lowers plasma trimethylamine n-oxide concentrations in apolipoprotein e−/− mice. Sci Rep [Internet]. 3 Oct. 2018 [cited 18 June 2024]; 8(1). Available on: https://doi.org/10.1038/s41598-018-33018-5
  12. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: a review. Brain Behav Immun [online]. Listop. 2017 [cited June 18, 2023];66:9-17. Available on: https://doi.org/10.1016/j.bbi.2017.01.016
  13. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano G, Gasbarrini A, Mele M. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms [Internet]. Jan 10. 2019 [cited 20 June 2023]; 7(1):14. Available on: https://doi.org/10.3390/microorganisms7010014
  14. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: metabolic and health benefits. British Journal of Nutrition [online]. Sickle. 2010 [cited 8 Feb. 2023]; 104(S2):S1—S63. Available on: https://doi.org/10.1017/s0007114510003363
  15. Rodrigues e-Lacerda R, Fang H, Robin N, Bhatwa A, Marko DM, Schertzer JD. Microbiota and Nod-like receptors balance inflammation and metabolism during obesity and diabetes. Biomed J [online]. Herbs. 2023 [cited December 20, 2023]:100610. Available on: https://doi.org/10.1016/j.bj.2023.100610
  16. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut [Internet]. September 1. 1980 [cited 15 Jan. 2023]; 21(9):793-8. Available on: https://doi.org/10.1136/gut.21.9.793
  17. Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-α: implications for insulin resistance. Diabetes [Internet]. 1 Nov. 2002 [cited December 28, 2022]; 51(11):3176-88. Available on: https://doi.org/10.2337/diabetes.51.11.3176
  18. Ruan Y, Sun J, He J, Chen F, Chen R, Chen H. Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials. Plos One [Internet]. 10 Jul 2015 [cited 8 Feb. 2023]; 10(7):e0132121. Available on: https://doi.org/10.1371/journal.pone.0132121
  19. Sabapathy V, Stremska ME, Mohammad S, Corey RL, Sharma PR, Sharma R. Novel immunomodulatory cytokine regulates inflammation, diabetes, and obesity to protect from diabetic nephropathy. Frontiers in Pharmacology [online]. May 22. 2019 [cited December 26, 2022];10. Available on: https://doi.org/10.3389/fphar.2019.00572
  20. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice [online]. Listop. 2019 [cited December 20, 2022];157:107843. Available on: https://doi.org/10.1016/j.diabres.2019.107843
  21. Salazar N, Arboleya S, Valdes L, Stanton C, Ross P, Ruiz L, Gueimonde M, Clara G de Los Reyes-Gavilan. The human intestinal microbiome at extreme ages of life. Dietary intervention as a way to counteract alterations. Front Genet [online]. 21 November. 2014 [cited 30 Apr 2023];5. Available on: https://doi.org/10.3389/fgene.2014.00406
  22. Samah S, Ramasamy K, Lim SM, Neoh CF. Probiotics for the management of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Research and Clinical Practice [online]. Sickle. 2016 [cited 8 Feb. 2023];118:172-82. Available on: https://doi.org/10.1016/j.diabres.2016.06.014
  23. Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology [online]. 11 Jul 2019 [cited 8 Feb 2023]; 16(10):605-16. Available on: https://doi.org/10.1038/s41575-019-0173-3
  24. Sanna S, van Zuydam NR, Mahajan A, Kurilshikov A, Vich Vila A, Võsa U, Mujagic Z, Masclee AA, Jonkers DM, Oosting M, Joosten LA, Netea MG, Franke L, Zhernakova A, Fu J, Wijmenga C, McCarthy MI. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nature Genetics [online]. 18 Feb. 2019 [cited January 15, 2023]; 51(4):600-5. Available on: https://doi.org/10.1038/s41588-019-0350-x
  25. Sarkar D, Chakraborty A, Saha A, Chandra AK. Iodine in excess in the alterations of carbohydrate and lipid metabolic pattern as well as histomorphometric changes in associated organs. Journal of Basic and Clinical Physiology and Pharmacology [Internet]. 27 November. 2018 [cited 29 September 2022]; 29(6):631-43. Available on: https://doi.org/10.1515/jbcpp-2017-0204
  26. Sasso JM, Ammar RM, Tenchov R, Lemmel S, Kelber O, Grieswelle M, Zhou QA. Gut microbiome–brain alliance: a landscape view into mental and gastrointestinal health and disorders. ACS Chem Neurosci [online]. May 8. 2023 [cited June 14, 2024]. Available on: https://doi.org/10.1021/acschemneuro.3c00127
  27. Scheithauer TP, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in Immunology [online]. 16 Oct. 2020 [cited December 20, 2022];11. Available at: https://doi.org/10.3389/fimmu.2020.571731
  28. Schmidt FM, Weschenfelder J, Sander C, Minkwitz J, Thormann J, Chittka T, Mergl R, Kirkby KC, Faßhauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLOS ONE [Internet]. March 17. 2015 [cited December 27, 2022]; 10(3):e0121971. Available on: https://doi.org/10.1371/journal.pone.0121971
  29. Schwartz S, Friedberg I, Ivanov IV, Davidson LA, Goldsby JS, Dahl DB, Herman D, Wang M, Donovan SM, Chapkin R. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biology [online]. 2012 [cited 14 Feb. 2023]; 13(4):R32. Available on: https://doi.org/10.1186/gb-2012-13-4-r32
  30. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity [Internet]. January. 2010 [cited 29 September 2022]; 18(1):190-5. Available on: https://doi.org/10.1038/oby.2009.167
  31. Segain JP. Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn’s disease. Gut [Internet]. September 1. 2000 [cited 15 Jan. 2023]; 47(3):397-403. Available at: https://doi.org/10.1136/gut.47.3.397
  32. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infection and Immunity [Internet]. 1 Nov. 1998 [cited 7 Feb. 2023]; 66(11):5224-31. Available on: https://doi.org/10.1128/iai.66.11.5224-5231.1998
  33. Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. Journal of Experimental Medicine [Internet]. Jan 16. 2018 [cited 7 Feb 2023]; 215(2):383-96. Available on: https://doi.org/10.1084/jem.20171965
  34. Shariff S, Kwan Su Huey A, Parag Soni N, Yahia A, Hammoud D, Nazir A, Uwishema O, Wojtara M. Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease. Ann Med Amp Surg [Internet]. Jan 18. 2024 [cited June 14, 2024]. Available on: https://doi.org/10.1097/ms9.0000000000001744
  35. Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Yoshiya K, Matsushima A, Sumi Y, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H. Altered gut flora and environment in patients with severe SIRS. The Journal of Trauma: Injury, Infection, and Critical Care [online]. January. 2006 [cited December 19, 2022]; 60(1):126-33. Available on: https://doi.org/10.1097/01.ta.0000197374.99755.fe
  36. Simpson HL, Campbell BJ. Review article: dietary fibre-microbiota interactions. Alimentary Pharmacology & Therapeutics [online]. May 24. 2015 [cited 8 Feb. 2023]; 42(2):158-79. Available on: https://doi.org/10.1111/apt.13248
  37. Singh P, Elhaj DA, Ibrahim I, Abdullahi H, Al Khodor S. Maternal microbiota and gestational diabetes: impact on infant health. J Transl Med [Internet]. 6 June. 2023 [cited 23 Jul 2023]; 21(1). Available on: https://doi.org/10.1186/s12967-023-04230-3
  38. Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Bäckhed F, Ohlsson C. The gut microbiota regulates bone mass in mice. Journal of Bone and Mineral Research [online]. May 17. 2012 [cited 29 September 2022]; 27(6):1357-67. Available on: https://doi.org/10.1002/jbmr.1588
  39. So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. The American Journal of Clinical Nutrition [online]. May 11. 2018 [cited 8 Feb. 2023]; 107(6):965-83. Available on: https://doi.org/10.1093/ajcn/nqy041
  40. Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Diet-induced extinctions in the gut microbiota compound over generations. Nature [online]. January. 2016 [cited 13 Jan. 2023]; 529(7585):212-5. Available on: https://doi.org/10.1038/nature16504
  41. Stewart CJ, Ajami NJ, O'Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature [online]. Oct. 2018 [cited 20 Feb. 2023]; 562(7728):583-8. Available on: https://doi.org/10.1038/s41586-018-0617-x
  42. Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nature Medicine [online]. Herbs. 2019 [cited 8 Feb 2023]; 25(5):716-29. Available on: https://doi.org/10.1038/s41591-019-0439-x
  43. Sun J, Buys NJ. Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials. British Journal of Nutrition [online]. 22 Feb. 2016 [cited 8 Feb. 2023]; 115(7):1167-77. Available at: https://doi.org/10.1017/s0007114516000076
  44. Sun M, Wu W, Chen L, Yang W, Huang X, Ma C, Chen F, Xiao Y, Zhao Y, Ma C, Yao S, Carpio VH, Dann SM, Zhao Q, Liu Z, Cong Y. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nature Communications [online]. September 3. 2018 [cited 7 Feb 2023]; 9(1). Available on: https://doi.org/10.1038/s41467-018-05901-2
  45. Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L, Lou C, Cao X, Chen X, Li B, Wang B, Zhao J. Lactic acid-producing probiotic saccharomyces cerevisiae attenuates ulcerative colitis via suppressing macrophage pyroptosis and modulating gut microbiota. Front Immunol [Internet]. 24 Nov. 2021 [cited June 23, 2024];12. Available on: https://doi.org/10.3389/fimmu.2021.777665
  46. Tabor E. Comment on “gut microbiome: what we do and don’t know”. Nutrition in Clinical Practice [online]. May 11. 2016 [cited 2 October 2022]; 31(3):416. Available on: https://doi.org/10.1177/0884533616634865
  47. Tette FM, Kwofie SK, Wilson MD. Therapeutic anti-depressant potential of microbial GABA produced by Lactobacillus rhamnosus strains for GABAergic signaling restoration and inhibition of addiction-induced HPA axis hyperactivity. Current Issues in Molecular Biology [online]. 22 Mar. 2022 [cited December 19, 2022]; 44(4):1434-51. Available at: https://doi.org/10.3390/cimb44040096
  48. Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, etc. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science [online]. 8 Mar. 2018 [cited 18 Jan. 2023]; 359(6382):1376-83. Available on: https://doi.org/10.1126/science.aar3318
  49. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology [online]. 29 Oct. 2010 [cited 8 Feb. 2023]; 52(5):1836-46. Available on: https://doi.org/10.1002/hep.24001
  50. Timper K, Dalmas E, Dror E, Rütti S, Thienel C, Sauter NS, Bouzakri K, Bédat B, Pattou F, Kerr-Conte J, Böni-Schnetzler M, Donath MY. Glucose-dependent insulinotropic peptide stimulates glucagon-like peptide 1 production by pancreatic islets via interleukin 6, produced by α cells. Gastroenterology [Internet]. July. 2016 [cited 28 December 2022]; 151(1):165-79. Available on: https://doi.org/10.1053/j.gastro.2016.03.003
  51. Tirosh A, Calay ES, Tuncman G, Claiborn KC, Inouye KE, Eguchi K, Alcala M, Rathaus M, Hollander KS, Ron I, Livne R, Heianza Y, Qi L, Shai I, Garg R, Hotamisligil GS. The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans. Science Translational Medicine [online]. 24 Apr. 2019 [cited 7 Feb. 2023]; 11(489):eaav0120. Available on: https://doi.org/10.1126/scitranslmed.aav0120
  52. Tran HQ, Ley RE, Gewirtz AT, Chassaing B. Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases. Nature Communications [online]. Dec. 2019 [cited 18 Jan. 2023]; 10(1). Available on: https://doi.org/10.1038/s41467-019-13538-y
  53. Trinh B, Donath MY, Läubli H. Successful treatment of immune checkpoint inhibitor–induced diabetes with infliximab. Diabetes Care [online]. 15 Jul 2019 [cited December 28, 2022]; 42(9):e153-e154. Available on: https://doi.org/10.2337/dc19-0908
  54. Tsao CH, Shiau MY, Chuang PH, Chang YH, Hwang J. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. Journal of Lipid Research [online]. 17 Dec. 2013 [cited December 27, 2022]; 55(3):385-97. Available on: https://doi.org/10.1194/jlr.m041392
  55. Udayappan SD, Kovatcheva-Datchary P, Bakker GJ, Havik SR, Herrema H, Cani PD, et al. Intestinal Ralstonia pickettii augments glucose intolerance in obesity. PLOS ONE [Internet]. 22 Nov. 2017 [cited 18 Jan. 2023]; 12(11):e0181693. Available on: https://doi.org/10.1371/journal.pone.0181693
  56. Ungurianu A, Zanfirescu A, Grădinaru D, Ionescu-Tîrgoviște C, Dănciulescu Miulescu R, Margină D. Interleukins and redox impairment in type 2 diabetes mellitus: mini-review and pilot study. Curr Med Res Opin [Internet]. 6 Feb. 2022 [cited 21 June 2023]; 38(4):511-22. Available on: https://doi.org/10.1080/03007995.2022.2033049
  57. Van Den Munckhof IC, Kurilshikov A, ter Horst R, Riksen NP, Joosten LA, Zhernakova A, Fu J, Keating ST, Netea MG, de Graaf J, Rutten JH. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obesity Reviews [online]. 24 Aug. 2018 [cited 15 Jan. 2023]; 19(12):1719-34. Available on: https://doi.org/10.1111/obr.12750
  58. Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annual Review of Immunology [online]. March 21. 2013 [cited December 27, 2022]; 31(1):317-43. Available on: https://doi.org/10.1146/annurev-immunol-032712-095906
  59. Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. The Journal of Immunology [Internet]. 28 Oct. 2009 [cited 7 Feb. 2023]; 183(10):6251-61. Available on: https://doi.org/10.4049/jimmunol.0803978
  60. Victor AR, Nalin AP, Dong W, McClory S, Wei M, Mao C, et al. IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB. The Journal of Immunology [Internet]. 25 Aug. 2017 [cited 6 Feb. 2023]; 199(7):2333-42. Available on: https://doi.org/10.4049/jimmunol.1601554
  61. Villalobos-Labra R, Subiabre M, Toledo F, Pardo F, Sobrevia L. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Mol Asp Med [Internet]. Apr. 2019 [cited December 20, 2023];66:49-61. Available on: https://doi.org/10.1016/j.mam.2018.11.001
  62. Virili C, Centanni M. “With a little help from my friends” – The role of microbiota in thyroid hormone metabolism and enterohepatic recycling. Molecular and Cellular Endocrinology [online]. Dec. 2017 [cited September 29, 2022];458:39-43. Available on: https://doi.org/10.1016/j.mce.2017.01.053
  63. Virili C, Fallahi P, Antonelli A, Benvenga S, Centanni M. Gut microbiota and Hashimoto’s thyroiditis. Reviews in Endocrine and Metabolic Disorders [online]. 8 Oct. 2018 [cited 29 September 2022]; 19(4):293-300. Available on: https://doi.org/10.1007/s11154-018-9467-y
  64. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, etc. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology [Internet]. Oct. 2012 [cited 8 Feb. 2023]; 143(4):913-6. Available on: https://doi.org/10.1053/j.gastro.2012.06.031
  65. Wang J, Shi ZH, Yang J, Wei Y, Wang XY, Zhao YY. Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters. Chin Med J [online]. Herbs. 2020 [cited 18 June 2024]; 133(9):1057-65. Available on: https://doi.org/10.1097/cm9.0000000000000734
  66. Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama Vlieg JE, Strissel K, Zhao L, Obin M, Shen J. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. The ISME Journal [online]. 17 June. 2014 [cited 8 Feb. 2023]; 9(1):1-15. Available on: https://doi.org/10.1038/ismej.2014.99
  67. Wang X, Ota N, Manzanillo P, Kates L, Zavala-Solorio J, Eidenschenk C, Zhang J, Lesch J, Lee WP, Ross J, Diehl L, van Bruggen N, Kolumam G, Ouyang W. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature [online]. 6 Aug. 2014 [cited 6 Feb. 2023]; 514(7521):237-41. Available on: https://doi.org/10.1038/nature13564
  68. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ, Fu X, Hazen JE, Krajcik D, DiDonato JA, Lusis AJ, Hazen SL. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell [Internet]. Dec. 2015 [cited 7 Feb. 2023]; 163(7):1585-95. Available on: https://doi.org/10.1016/j.cell.2015.11.055
  69. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, Mataki C, Sato H, Tanigawara Y, Schoonjans K, Itoh H, Auwerx J. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. Journal of Biological Chemistry [Internet]. 1 June. 2011 [cited 7 Feb. 2023]; 286(30):26913-20. Available on: https://doi.org/10.1074/jbc.m111.248203
  70. Watanabe Y, Nagai Y, Takatsu K. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance. Nutrients [online]. September 23. 2013 [cited December 28, 2022]; 5(9):3757-78. Available at: https://doi.org/10.3390/nu5093757
  71. Wiciński M, Gębalski J, Gołębiewski J, Malinowski B. Probiotics for the treatment of overweight and obesity in humans - a review of clinical trials. Microorganisms [Internet]. 29 Jul 2020 [cited 12 August 2023]; 8(8):1148. Available on: https://doi.org/10.3390/microorganisms8081148
  72. Wu X, Li Q, Lin D, Cai J, Huang H, Tan H. Gut microbiota and hypertensive disorders in pregnancy: evidence from the Mendelian randomization study. Aging [Internet]. September 11. 2023 [cited June 18, 2024]. Available on: https://doi.org/10.18632/aging.205019
  73. www.moz.gov.ua. Official website of the Ministry of Health of Ukraine; [cited 20 September 2020]
  74. www.who.int/country/ukr/en. World Health Organization (WHO); [cited 20 September 2020].
  75. Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M, Sun L, Xue Z, Wang J, Feng J, Yan F, Zhao N, Liu J, Long W, Zhao L. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiology Ecology [online]. 21 Oct. 2013 [cited 8 Feb. 2023]; 87(2):357-67. Available on: https://doi.org/10.1111/1574-6941.12228
  76. Xu E, Pereira MM, Karakasilioti I, Theurich S, Al-Maarri M, Rappl G, Waisman A, Wunderlich FT, Brüning JC. Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance. Nature Communications [online]. 3 May. 2017 [cited December 28, 2022]; 8(1). Available at: https://doi.org/10.1038/ncomms14803
  77. Xu H, Pan LB, Yu H, Han P, Fu J, Zhang ZW, Hu JC, Yang XY, Keranmu A, Zhang HJ, Bu MM, Jiang JD, Wang Y. Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics. Front Pharmacol [online]. September 27. 2022 [cited 23 June 2024];13. Available on: https://doi.org/10.3389/fphar.2022.919181
  78. Yao K, Zeng L, He Q, Wang W, Lei J, Zou X. Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Medical Science Monitor [online]. 22 June. 2017 [cited 8 Feb. 2023];23:3044-53. Available on: https://doi.org/10.12659/msm.902600
  79. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. Human gut microbiome viewed across age and geography. Nature [online]. May 9. 2012 [cited 30 Apr 2023]; 486(7402):222-7. Available on: https://doi.org/10.1038/nature11053
  80. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized nutrition by prediction of glycemic responses. Cell [Internet]. Listop. 2015 [cited 8 Feb. 2023]; 163(5):1079-94. Available on: https://doi.org/10.1016/j.cell.2015.11.001
  81. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, Zecchi R, D’Angelo C, Massi-Benedetti C, Fallarino F, Carvalho A, Puccetti P, Romani L. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity [Internet]. Sickle. 2013 [cited 6 Feb. 2023]; 39(2):372-85. Available on: https://doi.org/10.1016/j.immuni.2013.08.003
  82. Zeng C, Tan H. Advances in experimental medicine and biology [online]. Singapore: Springer Singapore; 2020. Gut Microbiota and Heart, Vascular Injury; [cited 9 Nov. 2022]; pp. 107-41. Available on: https://doi.org/10.1007/978-981-15-2385-4_8
  83. Zhang C, Jiang J, Wang C, Li S, Yu L, Tian F, Zhao J, Zhang H, Chen W, Zhai Q. Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults. Clin Nutr [Internet]. February. 2022 [cited 12 Aug. 2023]; 41(2):365-73. Available on: https://doi.org/10.1016/j.clnu.2021.11.037
  84. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? American Journal of Gastroenterology [online]. Listop. 2012 [cited 8 Feb. 2023]; 107(11):1755. Available on: https://doi.org/10.1038/ajg.2012.251
  85. Zhang X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y, Li X, Ning G, Zhao L. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS ONE [Internet]. 3 Aug. 2012 [cited 8 Feb. 2023]; 7(8):e42529. Available on: https://doi.org/10.1371/journal.pone.0042529
  86. Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, etc. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science [online]. 8 Mar. 2018 [cited 7 Feb 2023]; 359(6380):1151-6. Available at: https://doi.org/10.1126/science.aao5774
  87. Zhao Q, Elson CO. Adaptive immune education by gut microbiota antigens. Immunology [Internet]. 8 Feb. 2018 [cited 31 Jan. 2023]; 154(1):28-37. Available on: https://doi.org/10.1111/imm.12896
  88. Zheng W, Xu Q, Huang W, Yan Q, Chen Y, Zhang L, Tian Z, Liu T, Yuan X, Liu C, Luo J, Guo C, Song W, Zhang L, Liang X, Qin H, Li G. Gestational diabetes mellitus is associated with reduced dynamics of gut microbiota during the first half of pregnancy. MSystems [Internet]. March 24. 2020 [cited 23 Jul 2023]; 5(2). Available on: https://doi.org/10.1128/msystems.00109-20
  89. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr [Internet]. 3 Aug. 2011 [cited 30 Apr 2023]; 66(1):53-60. Available on: https://doi.org/10.1038/ejcn.2011.141
  90. Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell [Internet]. Heather. 2018 [cited 8 Feb. 2023]; 174(6):1388-405. Available on: https://doi.org/10.1016/j.cell.2018.08.041
  91. Zubcevic J, Richards EM, Yang T, Kim S, Sumners C, Pepine CJ, Raizada MK. Impaired autonomic nervous system-microbiome circuit in hypertension. Circulation Research [online]. 21 June. 2019 [cited 9 Nov. 2022]; 125(1):104-16. Available on: https://doi.org/10.1161/circresaha.119.313965